Psychiatry and Neurology, Neurology · Burlington, VT
NPI
1396090254
Since 2012
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
111 Colchester Ave
Burlington, VT, 05401
Phone (802) 847-2788
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
827 services
Medicare patients, 2024
93
Average age 62
Drug cost, 2024
$823K
940 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam Sprouse Blum was code 64615 (musculoskeletal), 139 times for 47 patients. In total Adam Sprouse Blum billed 827 services in 10 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64615 Musculoskeletal | Office | 139 | 47 | $80.96 | $11K |
| 99214 Office E&M - Established | Office | 35 | 32 | $78.74 | $2,756 |
| 99213 Office E&M - Established | Office | 25 | 22 | $56.18 | $1,405 |
By year: 2022 $21K for 1,454 services; 2023 $18K for 820 services; 2024 $19K for 827 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam Sprouse Blum prescribed most often to Medicare patients was Ajovy Autoinjector (Fremanezumab-Vfrm), with 127 prescriptions and refills. In total Adam Sprouse Blum wrote 940 Medicare prescriptions that cost $823K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ajovy Autoinjector Fremanezumab-Vfrm | 127 | 267 | 30 | $193K |
| Ubrelvy Ubrogepant | 107 | 107 | 30 | $138K |
| Emgality Pen Galcanezumab-Gnlm | 91 | 213 | 26 | $155K |
| Nurtec Odt Rimegepant Sulfate | 88 | 88 | 20 | $115K |
| Amlodipine Besylate Generic | 78 | 197 | 24 | $501 |
| Qulipta Atogepant | 59 | 83 | 15 | $90K |
| Aimovig Autoinjector Erenumab-Aooe | 52 | 112 | 13 | $85K |
| Rizatriptan Rizatriptan Benzoate | 51 | 51 | 13 | $995 |
| Sumatriptan Succinate Generic | 39 | 41 | Under 11 | $382 |
| Topiramate Generic | 37 | 107 | Under 11 | $659 |
| Eletriptan Hbr Eletriptan Hydrobromide | 35 | 35 | 12 | $2,902 |
| Topiramate Er Topiramate | 26 | 40 | Under 11 | $14K |
| Naratriptan Hcl Generic | 22 | 26 | Under 11 | $679 |
| Divalproex Sodium Er Divalproex Sodium | 19 | 29 | Under 11 | $507 |
| Sumatriptan Generic | 15 | 15 | Under 11 | $1,229 |
Brand drugs: 551 claims; generic drugs: 389 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Adam Sprouse Blum were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.